The nurse is talking with a parent who decides to decline treatment for a 3-year-old client whose cancer has metastasized. There is a conflict between the parents and the rest of the family regarding withdrawal of care from the child
When determining the appropriate action, the nurse initially considers: 1. The age of the child.
2. The values of the parents.
3. The beliefs of the child.
4. The values of the rest of the family.
2. The values of the parents.
Rationale:
When confronted with a conflict regarding care, one of the first actions by the nurse is to consider the values and beliefs of the parents who are making the decision. The age of the child is not a relevant factor in the decision making if the child is under 18 years. The child is too young to have values and beliefs. The nurse is respectful with the rest of the family but should consider the parents' decision only.
You might also like to view...
An older client has been overusing alcohol for 25 years. Which nutrients should the nurse recommend that this client increase ingesting?
a. Vitamin D b. Potassium and iron c. Potassium and calcium d. Thiamine and folic acid
The pediatric nurse caring for children with endocrine disorders teaches the student nurse that the polyendocrine deficiency syndrome is classified into two separate forms referred to as type I and type II
The nurse further states that type I occurs in children and is accompanied by: Select all answers that apply. A) chronic active hepatitis. B) chronic candida infections. C) overactive parathyroid glands. D) precocious sexual development.
The nurse is instructing a pregnant patient about the influence of teratogens on the embryo. Which weeks of gestation are considered the embryonic stage?
A) Week 2 to week 8 B) Week 9 to birth C) Fertilization to the week 2 D) The entire pregnancy
The nurse is describing the phases of treatment to a child who was diagnosed with leukemia and his parents. How would the nurse describe the induction stage?
A) Intense therapy to strengthen remission B) Rapid promotion of complete remission C) Elimination of all residual leukemic cells D) Reduction of risk for central nervous system (CNS) disease